前列腺影像引导VMAT膀胱充盈标准的剂量学依据
本研究纳入20例因膀胱充盈不达标而重复CT模拟定位的前列腺放疗患者,比较基于「拒绝」与「接受」膀胱状态优化的VMAT计划的膀胱剂量。结果显示使用「拒绝」膀胱计划在59%分次中膀胱剂量降低≥5%,且严重剂量违规分次更少;建议膀胱高度20-40mm作为充盈可接受范围。
要点
- 膀胱高度20-40mm(膀胱顶至耻骨联合上缘)可作为前列腺放疗膀胱充盈可接受范围。
- 较短膀胱优化的计划膀胱受量更低、方案剂量约束依从性更好。
- 基于「接受」膀胱计划治疗时30/175分次出现严重膀胱剂量违规。
关键影像表现/征象
- 发生严重膀胱剂量违规的30个膀胱显著短于无严重违规者(平均28mm vs 43mm,p<0.05)。
诊断标准与关键数值
- 膀胱高度范围20-40mm(膀胱顶至耻骨联合上缘测量)推荐为前列腺放疗充盈膀胱方案的可接受标准。
- 严重膀胱剂量违规定义为膀胱剂量差异>5%。
- 使用「接受」膀胱计划治疗时,30/175分次出现严重剂量违规。
- 「拒绝」膀胱计划在59%分次中膀胱剂量较「接受」膀胱计划降低≥5%,严重剂量违规分次数为17。
临床应用与阅片要点
- 日常阅片或CBCT验证时可测量膀胱顶至耻骨联合上缘高度,20-40mm提示充盈可接受。
- 膀胱过短(如平均28mm)与严重剂量违规相关,需考虑重新定位或调整计划。
局限性
- 单中心小样本(20例)研究,结论需多中心验证。
- 重复CT模拟定位患者可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Repeated CT simulation imaging is common at our institution due to failure to achieve acceptable bladder filling in patients undergoing prostate radiotherapy. There is operational value in re-assessing the validity of the bladder filling assessment criteria by comparing the quality of two plans optimized based on either an "Accepted" or "Rejected" bladder status.
METHODS: Twenty prostate patients with repeated CT simulation imaging were included. For each patient, a VMAT plan created using the "Rejected" bladder was compared with the "Accepted" bladder plan. Then, delivered dose to bladder was estimated using ≥4 CBCTs to measure number of fractions with major bladderdose violation (>5% difference) for both plans. Bladder heights of fractions without major bladder dose violations were compared to those with a violation to determine a threshold height for bladder filling acceptability.
RESULTS: Using the "Accepted" bladder plans for treatment resulted in 30/175 fractions with major dose violations. These 30 bladders were significantly shorter than those without major violation (mean 28 vs 43mm, p < 0.05). The "Rejected" bladder plans delivered a lower dose to the bladder by ≥5% than the '"Accepted" bladder plans in 59% of fractions, and the number of fractions with major dose violations was 17.
CONCLUSIONS: Using a shorter bladder for plan optimization resulted in better bladder sparing during treatment and improved compliance to protocol specific bladder dose constraints. A bladder height range of 20-40 mm measured between the bladder dome and the superior aspect of the symphysis pubis is recommended for prostate radiotherapy requiring a full bladder protocol.
ADVANCES IN KNOWLEDGE: Using real patient data from simulation and treatment, this study established a range of bladder height that can be measured easily in a clinical setting for assessing adequacy of bladder filling for prostate radiotherapy.
引用
- Kong, Dang, Wan, et al. The dosimetric underpinning of bladder filling criteria for prostate image-guided volumetric modulated arc therapy. Br J Radiol. 2023. PMID: 37086060. doi:10.1259/bjr.20230020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。